Keyphrases
Bromodomain
100%
Kinase Inhibitor
100%
Bromodomain-containing Protein 4 (BRD4)
100%
Acetyl-lysine
100%
Lysine Binding Sites
100%
Binding Site
28%
In Cancer
14%
Rational Design
14%
High Selectivity
14%
Drug Target
14%
BI2536
14%
Histone
14%
Contraception
14%
Chemical Scaffolds
14%
IC50
14%
Binding Mode
14%
Inhibitory Potential
14%
Screening Campaign
14%
Dual Activity
14%
Binding Scaffold
14%
Comparative Structural Analysis
14%
PLK1 Inhibitor
14%
Terminal Protein
14%
Cancer-related Inflammation
14%
Structural Framework
14%
Promising Drug
14%
Acetylated Lysine
14%
Crystallization Screening
14%
JAK2 Inhibitor
14%
Selective Activity
14%
Co-crystallization
14%
Kinase Inhibitor Design
14%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Site
100%
Phosphotransferase Inhibitor
100%
Acetic Acid Derivative
100%
Lysine
100%
Crystallization
20%
Malignant Neoplasm
20%
Histone
20%
Phosphotransferase
20%
N Tert Butyl 3 [5 Methyl 2 [4 (4 Methyl 1 Piperazinyl)phenylamino] 4 Pyrimidinylamino]benzenesulfonamide
20%
Janus Kinase 2 Inhibitor
20%
4 (8 Cyclopentyl 7 Ethyl 5,6,7,8 Tetrahydro 5 Methyl 6 Oxo 2 Pteridinylamino) 3 Methoxy N (1 Methyl 4 Piperidinyl)benzamide
20%
IC50
20%
Inflammation
20%
Biochemistry, Genetics and Molecular Biology
Bromodomain
100%
Binding Site
100%
Phosphotransferase
100%
Kinase
100%
Lysine
100%
PLK1
9%
IC50
9%
Janus Kinase
9%
Histone
9%